Sjögren's syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of Sjögren's syndrome is approximately 4 per 100,000 individuals worldwide.<ref name="pmid11393497">{{cite journal |vauthors=Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ, O'Fallon WM, Fox PC |title=Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota |journal=Mayo Clin. Proc. |volume=76 |issue=6 |pages=593–9 |date=June 2001 |pmid=11393497 |doi=10.4065/76.6.593 |url=}}</ref> | *The incidence of Sjögren's syndrome is approximately 4 per 100,000 individuals worldwide.<ref name="pmid11393497">{{cite journal |vauthors=Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ, O'Fallon WM, Fox PC |title=Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota |journal=Mayo Clin. Proc. |volume=76 |issue=6 |pages=593–9 |date=June 2001 |pmid=11393497 |doi=10.4065/76.6.593 |url=}}</ref><ref name="pmid23983119">{{cite journal |vauthors=Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, Leroux JL, Mariette X, Mahr A |title=Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area |journal=Arthritis Care Res (Hoboken) |volume=66 |issue=3 |pages=454–63 |date=March 2014 |pmid=23983119 |doi=10.1002/acr.22115 |url=}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
*The prevalence of Sjögren's syndrome is approximately 43 per 100,000 individuals worldwide.<ref name="pmid24938285">{{cite journal |vauthors=Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R |title=Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis |journal=Ann. Rheum. Dis. |volume=74 |issue=11 |pages=1983–9 |date=November 2015 |pmid=24938285 |doi=10.1136/annrheumdis-2014-205375 |url=}}</ref> | *The prevalence of Sjögren's syndrome is approximately 43 per 100,000 individuals worldwide.<ref name="pmid24938285">{{cite journal |vauthors=Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R |title=Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis |journal=Ann. Rheum. Dis. |volume=74 |issue=11 |pages=1983–9 |date=November 2015 |pmid=24938285 |doi=10.1136/annrheumdis-2014-205375 |url=}}</ref><ref name="pmid9825745">{{cite journal |vauthors=Thomas E, Hay EM, Hajeer A, Silman AJ |title=Sjögren's syndrome: a community-based study of prevalence and impact |journal=Br. J. Rheumatol. |volume=37 |issue=10 |pages=1069–76 |date=October 1998 |pmid=9825745 |doi= |url=}}</ref> | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
| Line 16: | Line 16: | ||
===Age=== | ===Age=== | ||
* | *It can occur at any age, but the mean age is usually in the 4th to 5th decade.<ref name="pmid25114590">{{cite journal |vauthors=Patel R, Shahane A |title=The epidemiology of Sjögren's syndrome |journal=Clin Epidemiol |volume=6 |issue= |pages=247–55 |date=2014 |pmid=25114590 |pmc=4122257 |doi=10.2147/CLEP.S47399 |url=}}</ref> | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to | *There is no racial predilection to Sjögren's syndrome. | ||
===Gender=== | ===Gender=== | ||
*Female are more commonly affected by Sjögren's syndrome than male. The female to male ratio is approximately 9 to 1. | *Female are more commonly affected by Sjögren's syndrome than male. The female to male ratio is approximately 9 to 1. | ||
===Region=== | ===Region=== | ||
*The majority of Sjögren's syndrome cases are reported in | *The majority of Sjögren's syndrome cases are reported in China, Japan, and California.<ref name="pmid8468491">{{cite journal |vauthors=Kang HI, Fei HM, Saito I, Sawada S, Chen SL, Yi D, Chan E, Peebles C, Bugawan TL, Erlich HA |title=Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome |journal=J. Immunol. |volume=150 |issue=8 Pt 1 |pages=3615–23 |date=April 1993 |pmid=8468491 |doi= |url=}}</ref> | ||
=== | |||
=== | |||
==References== | ==References== | ||
Revision as of 20:48, 4 April 2018
|
Sjögren's syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sjögren's syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Sjögren's syndrome epidemiology and demographics |
|
Sjögren's syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Sjögren's syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Incidence
Prevalence
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- It can occur at any age, but the mean age is usually in the 4th to 5th decade.[5]
Race
- There is no racial predilection to Sjögren's syndrome.
Gender
- Female are more commonly affected by Sjögren's syndrome than male. The female to male ratio is approximately 9 to 1.
Region
- The majority of Sjögren's syndrome cases are reported in China, Japan, and California.[6]
References
- ↑ Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ, O'Fallon WM, Fox PC (June 2001). "Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota". Mayo Clin. Proc. 76 (6): 593–9. doi:10.4065/76.6.593. PMID 11393497.
- ↑ Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, Leroux JL, Mariette X, Mahr A (March 2014). "Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area". Arthritis Care Res (Hoboken). 66 (3): 454–63. doi:10.1002/acr.22115. PMID 23983119.
- ↑ Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R (November 2015). "Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis". Ann. Rheum. Dis. 74 (11): 1983–9. doi:10.1136/annrheumdis-2014-205375. PMID 24938285.
- ↑ Thomas E, Hay EM, Hajeer A, Silman AJ (October 1998). "Sjögren's syndrome: a community-based study of prevalence and impact". Br. J. Rheumatol. 37 (10): 1069–76. PMID 9825745.
- ↑ Patel R, Shahane A (2014). "The epidemiology of Sjögren's syndrome". Clin Epidemiol. 6: 247–55. doi:10.2147/CLEP.S47399. PMC 4122257. PMID 25114590.
- ↑ Kang HI, Fei HM, Saito I, Sawada S, Chen SL, Yi D, Chan E, Peebles C, Bugawan TL, Erlich HA (April 1993). "Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome". J. Immunol. 150 (8 Pt 1): 3615–23. PMID 8468491.